Sign up to access all valuation multiples
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into three segments based on end market: Medical, which develops complex product systems, components, and packaging solutions for pharmaceuticals and supplements; Integrated, which develops subsystems for mobile phones; and Industrial, which develops systems for the automotive, hygiene, packaging, and furniture industries. Roughly a third of the firm's revenue is generated in the Rest of Europe.
1938
5.8K+
LTM Revenue $1.0B
LTM EBITDA $168M
$1.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of September 2025, Nolato reported last 12-month revenue of $1.0B and EBITDA of $168M.
In the same period, Nolato generated $175M in LTM gross profit and $80.8M in net income.
See Nolato valuation multiples based on analyst estimatesIn the most recent fiscal year, Nolato reported revenue of $1.0B and EBITDA of $159M.
Nolato expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nolato valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| Gross Profit | $175M | XXX | $170M | XXX | XXX | XXX |
| Gross Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA | $168M | XXX | $159M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBIT | $107M | XXX | $94.3M | XXX | XXX | XXX |
| EBIT Margin | 11% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $80.8M | XXX | $69.2M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $70.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nolato has current market cap of SEK 15.5B (or $1.6B), and EV of SEK 16.4B (or $1.7B).
As of October 17, 2025, Nolato's stock price is SEK 58 (or $6).
See Nolato trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $1.6B | XXX | XXX | XXX | XXX | $0.31 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialNolato's trades at 1.7x EV/Revenue multiple, and 10.8x EV/EBITDA.
See valuation multiples for Nolato and 15K+ public compsAs of October 17, 2025, Nolato has market cap of $1.6B and EV of $1.7B.
Equity research analysts estimate Nolato's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nolato has a P/E ratio of 20.2x.
| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 10.2x | XXX | 10.8x | XXX | XXX | XXX |
| EV/EBIT | 16.1x | XXX | 18.3x | XXX | XXX | XXX |
| EV/Gross Profit | 9.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 20.2x | XXX | 23.6x | XXX | XXX | XXX |
| EV/FCF | 35.6x | XXX | 22.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNolato's last 12 month revenue growth is 5%
Nolato's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $13K for the same period.
Nolato's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nolato's rule of X is 28% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nolato and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | 18% | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 28% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $13K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nolato acquired XXX companies to date.
Last acquisition by Nolato was XXXXXXXX, XXXXX XXXXX XXXXXX . Nolato acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Nolato founded? | Nolato was founded in 1938. |
| Where is Nolato headquartered? | Nolato is headquartered in Sweden. |
| How many employees does Nolato have? | As of today, Nolato has 5.8K+ employees. |
| Who is the CEO of Nolato? | Nolato's CEO is Mr. Christer Wahlquist. |
| Is Nolato publicy listed? | Yes, Nolato is a public company listed on STO. |
| What is the stock symbol of Nolato? | Nolato trades under NOLA B ticker. |
| When did Nolato go public? | Nolato went public in 1984. |
| Who are competitors of Nolato? | Similar companies to Nolato include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nolato? | Nolato's current market cap is $1.6B |
| What is the current revenue of Nolato? | Nolato's last 12 months revenue is $1.0B. |
| What is the current revenue growth of Nolato? | Nolato revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Nolato? | Current revenue multiple of Nolato is 1.7x. |
| Is Nolato profitable? | Yes, Nolato is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nolato? | Nolato's last 12 months EBITDA is $168M. |
| What is Nolato's EBITDA margin? | Nolato's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Nolato? | Current EBITDA multiple of Nolato is 10.2x. |
| What is the current FCF of Nolato? | Nolato's last 12 months FCF is $48.4M. |
| What is Nolato's FCF margin? | Nolato's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Nolato? | Current FCF multiple of Nolato is 35.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
